Clinical Trial Update: Sacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural Tanzania [Phase 4]

View source ↗

Summary

Phase 4 trial update on sacubitril-valsartan in patients with heart failure with reduced ejection fraction in rural Tanzania; currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: Martin Rohacek | Conditions: Heart Failure | Phase 4 | Status: NOT_YET_RECRUITING